Consensus Hyloris Pharmaceuticals SA

Equities

HYL

BE0974363955

Real-time Euronext Bruxelles Other stock markets 09:07:36 26/04/2024 pm IST			5-day change	1st Jan Change
11.7 ^EUR	-1.27%		-2.09%	-8.24%

14/03	Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024	CI
14/03	Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024

Evolution of the average Target Price on Hyloris Pharmaceuticals SA

Price target over the last 5 years

History of analyst recommendation changes

54284ea7c6c8f510417b35581b011054.P4g74Dx2T6XZvjymjtI3h2e__7zOBiYQr5mVgMSp8Wg.VN5rkWUxKNWQjWvl_7d93x2GjvCabF4l5fD5ypDExg1P3nmkUR0K8b30dQ~50b634498355469df4fbc0ed3db90fb9

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.7 EUR

Average target price

21.55 EUR

Spread / Average Target

+84.19%

High Price Target

22.1 EUR

Spread / Highest target

+88.89%

Low Price Target

21 EUR

Spread / Lowest Target

+79.49%

Consensus detail

Consensus revision (last 18 months)

Ratings for Hyloris Pharmaceuticals SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar